MDimune and Evercyte form partnership for developing tumor-targeting EVs
MDimune and Evercyte form partnership for developing tumor-targeting EVs April 1, 2021, Seoul, Korea and Vienna, Austria MDimune Inc. and Evercyte GmbH announced a
By admin|2021-09-17T15:46:31+00:00April 9th, 2021|Extracellular vesicles|
MDimune and Evercyte form partnership for developing tumor-targeting EVs April 1, 2021, Seoul, Korea and Vienna, Austria MDimune Inc. and Evercyte GmbH announced a
By admin|2021-04-09T08:41:15+00:00April 9th, 2021|recent highlights gene editing|
Knock-out of CD46 in RPTEC/TERT1 cells Application: gene editing of human telomerized cells with CRISPR/Cas9 knock-out of CD46 in RPTEC/TERT1 cells using CRISPR
By admin|2021-04-09T08:36:56+00:00April 9th, 2021|recent highlights gene editing|
Overexpression of green fluorescent protein in endothelial cells Application: establishment of reporter cell lines from relevant and standardizable telomerized human cells transfection
By admin|2021-04-09T09:03:30+00:00April 9th, 2021|Recent highlights substance testing|
Scratch assay for monitoring skin cell proliferation / migration screening for substances that induce fibroblast growth application: identification of agents with potential to target impaired
By admin|2024-08-30T09:08:35+00:00April 9th, 2021|recent highlights EV|
Analysis of miRNA cargo of extracellular vesicles from Wharton´s Jelly derived mesenchymal stem cells WJ-MSC/TERT273 application: characterization and quality control for stable production of extracellular
By admin|2021-04-08T10:29:39+00:00April 8th, 2021|Recent highlights substance testing|
Study of myofibroblast differentiation monitoring the effect of exogenous factors on myofibroblast differentiation in a model using TGFß as inducer of alpha smooth muscle actin in fibroblasts
By admin|2021-08-01T13:20:10+00:00April 8th, 2021|Recent highlights substance testing|
3D spheroid assay for screening of angiogenesis modulators monitoring the effect of exogenous factors on sprout formation from endothelial spheroids as a measure for induction / inhibition
By admin|2021-04-08T10:07:15+00:00April 8th, 2021|Recent highlights substance testing|
Testing for cytokine targeting screening for drugs targeting Interleukin-17A (Il-17A) using human fibroblasts that release IL-6 upon IL-17A treatment application: identification of drugs that directly block
By admin|2021-04-09T09:08:06+00:00April 8th, 2021|recent highlights EV|
Scratch assay for monitoring skin cell proliferation/migration screening for substances that induce fibroblast growth application: identification of agents with potential to target impaired wound healing
By admin|2021-04-09T08:00:20+00:00April 8th, 2021|Recent highlights substance testing|
2D proliferation assay for angiogenic modulator screening monitoring the effect of exogenous factors on endothelial cell proliferation as a measure for induction / inhibition of angiogenesis